The Use of Digital Genetic Counselor (DGC) for BRCA1/2 Mutation Carrier Testing
NCT04038905 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2020-01-30
Summary
The DGC provides an end-to-end solution to the Oncogenetics screening process from participant registration to receipt of the genetic test results and their interpretation. These steps are provided using personalized animated videos.
Conditions
- BRCA Mutations
Sponsors & Collaborators
-
Sheba Medical Center
collaborator OTHER_GOV -
Igentify Ltd
lead INDUSTRY
Principal Investigators
-
Elon Pras, Prof. · Sheba Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-01
- Primary Completion
- 2021-04-30
- Completion
- 2022-04-30
More Related Trials
-
A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer
NCT01423890 ·Status: COMPLETED ·Phase: NA
-
Early Detection of Breast Cancer Using Tomosynthesis Imaging
NCT00637598 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Point Of Service Testing in MBC
NCT03983577 ·Status: UNKNOWN ·Phase: NA
-
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
NCT00040222 ·Status: COMPLETED
-
Use of an Ultra-rapid BRCA1/2 Status Screening Test in Diagnostic and Theranostic Indication: Performance and Interest for Patients and Practitioners
NCT06111417 ·Status: RECRUITING
-
Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
NCT00897455 ·Status: UNKNOWN
-
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery
NCT06127979 ·Status: RECRUITING ·Phase: NA
-
Digital Delivery of Information About Genetic Testing for Breast Cancer
NCT04842799 ·Status: COMPLETED ·Phase: NA
-
Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing
NCT00165152 ·Status: COMPLETED ·Phase: NA
-
Cancer Prevention in Women With a BRCA Mutation
NCT02225015 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
NCT06760507 ·Status: RECRUITING ·Phase: NA
-
Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions
NCT00262899 ·Status: COMPLETED ·Phase: PHASE3
-
Outcomes of Education and Counseling for BRCA1 Testing
NCT00001468 ·Status: COMPLETED
-
Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot
NCT04002986 ·Status: COMPLETED ·Phase: NA
-
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study
NCT00006421 ·Status: COMPLETED
-
Genetic Education in BRCA Families
NCT03544983 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study
NCT00006425 ·Status: COMPLETED
-
Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers
NCT04330716 ·Status: COMPLETED ·Phase: NA
-
Genomic Signatures to Predict Treatment Response
NCT02032745 ·Status: COMPLETED
-
(Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer
NCT02627703 ·Status: UNKNOWN
-
Effects of Rapid Genetic Counseling and Testing in Newly Diagnosed Breast Cancer Patients
NCT00783822 ·Status: COMPLETED ·Phase: NA
-
Lessons Learned From the Family Gene Toolkit
NCT02154633 ·Status: COMPLETED ·Phase: NA
-
Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients
NCT02625935 ·Status: COMPLETED
-
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
NCT03667417 ·Status: RECRUITING
-
Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations
NCT00700778 ·Status: TERMINATED ·Phase: NA